共 50 条
- [1] Education: An overview from the author of `Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients' [J]. JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 : 25 - 25
- [2] Education: An overview from the author of 'Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients' (vol 3, pg 25, 2021) [J]. JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (03):
- [4] Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections [J]. Infection, 2023, 51 : 475 - 482
- [8] Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients [J]. Intensive Care Medicine, 2013, 39 : 1253 - 1261
- [9] Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections [J]. JAC-ANTIMICROBIAL RESISTANCE, 2024, 6 (05):
- [10] Endemicity and diversification of carbapenem-resistant Acinetobacter baumannii in an intensive care unit [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 37